Literature DB >> 34270222

Ribosomal Synthesis of Macrocyclic Peptides with Linear γ4- and β-Hydroxy-γ4-amino Acids.

Emel Adaligil1, Aimin Song1, Christian N Cunningham1, Wayne J Fairbrother1.   

Abstract

Herein, we report the ribosomal elongation of linear γ4- and β-hydroxy-γ4-amino acids (statines) to expand the nonproteinogenic amino acid repertoire of natural product-like combinatorial peptide libraries. First, we demonstrated the successful ribosomal incorporation of four linear γ4-amino acids (γ4Gly, (S)-γ4Ala, (S)-γ4Nva, and (R)-γ4Leu) into a 10-mer macrocyclic peptide scaffold. Given the promising effects reported for statines on the cell permeability of macrocyclic peptides, we also designed and tested the ribosomal incorporation of six statines derived from Ala and d-val. Four Ala-derived statines were successfully incorporated into peptides, and γ4SAla3R-OH (GP2) showed a similar efficiency of incorporation to that of (S)-β2hAla and l-Ala. These new building blocks might confer the important pharmacological properties of protease resistance and membrane permeability to macrocyclic peptides and expand the diversity of future combinatorial peptide libraries that can be translated by the ribosome.

Entities:  

Year:  2021        PMID: 34270222     DOI: 10.1021/acschembio.1c00292

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  2 in total

1.  Computational Site Saturation Mutagenesis of Canonical and Non-Canonical Amino Acids to Probe Protein-Peptide Interactions.

Authors:  Jeffrey K Holden; Ryan Pavlovicz; Alberto Gobbi; Yifan Song; Christian N Cunningham
Journal:  Front Mol Biosci       Date:  2022-04-14

2.  Co-Crystal Structure-Guided Optimization of Dual-Functional Small Molecules for Improving the Peroxygenase Activity of Cytochrome P450BM3.

Authors:  Xiangquan Qin; Yiping Jiang; Jie Chen; Fuquan Yao; Panxia Zhao; Longyi Jin; Zhiqi Cong
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.